Skip to main content

Table 3 Spearman’s rho correlational analysis between urinary uroporphyrin concentration, symptoms, and SF-12 0–100 scores

From: Health-related quality of life in porphyria cutanea tarda: a cross-sectional registry based study

  Total Women Men
Uroporphyrins Symptoms Uroporphyrins Symptoms Uroporphyrins Symptoms
Symptoms .219   .023   .344  
PCS −.202 −.441** −.133 −.364* −.284 −.614**
MCS −.186 −.354** −.129 −.353* −.230 −.379
Physical functioning −.178 −.350** −.105 −.343 −.206 −.352
Role physical −.258* −.406** −.152 −.414* −.342 −.422*
Bodily pain −.179 −.291* −.147 −.251 −.266 −.392*
General health −.133 −.372** −.014 −.258 −.265 −.574**
Vitality −.007 −.283* .033 −.356* −.055 −.230
Social functioning −.143 −.326* −.108 −.258 −.072 −.421*
Role emotional −.230 −.341** −.131 −.348* −.306 −.322
Mental health −.246 −.385** −.221 −.341 −.304 −.464*
  1. * p < .05; ** p < .01